Otsuka Holdings Co., Ltd. (TYO:4578)

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Japan Revenue	732.10B	718.10B	699.70B
North America Revenue	1.26T	1.17T	1.10T
Europe Revenue	328.10B	284.90B	242.90B
Others Revenue	301.60B	297.00B	292.20B
Overseas Revenue	1.89T	1.75T	1.63T

Revenue

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Pharmaceuticals Revenue	1.86T	1.74T	1.63T
Nutraceuticals Revenue	601.71B	577.62B	557.01B
Consumer Products Revenue	36.21B	34.61B	33.75B
Other Segment Revenue	120.53B	112.43B	110.07B

Adjusted EBIT

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Pharmaceuticals Business Profit	440.92B	402.02B	390.61B
Nutraceuticals Business Profit	71.58B	68.91B	64.15B
Consumer Products Business Profit	26.17B	25.17B	23.66B
Other Segment Business Profit	8.60B	7.47B	6.95B
Eliminations from Business Profit	-59.79B	-57.43B	-54.91B

EBIT

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Pharmaceuticals Segment Profit	480.36B	445.30B	285.11B
Nutraceuticals Segment Profit	57.89B	57.72B	59.78B
Consumer Products Segment Profit	26.10B	25.15B	23.00B
Other Segment Profit	9.14B	7.98B	7.53B
Eliminations from Segment Profit	-57.68B	-56.78B	-51.85B

Data Source: Fiscal.ai Last updated: Sep 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error